당뇨병 관리 앱 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 기능별, 플랫폼별, 구독 모델별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Diabetes Management Apps Market Trends:

The global diabetes management apps market was estimated at USD 1.87 billion in 2024 and is expected to expand at a CAGR of 8.5% from 2025 to 2030. This growth is primarily driven by the rising prevalence of diabetes, technological advancements, and innovation.

As digital technology continues to evolve, the market is anticipated to introduce a variety of innovations in diabetes management that significantly transform how the condition is managed.

In recent years, the number of smartphone applications designed for diabetes management has surged, with over a hundred apps currently available on online app stores to assist patients in tracking their blood glucose levels. Technological innovations are expected to drive growth in the diabetes management app industry. By incorporating AI into glucose monitoring applications, these advancements enhance predictive capabilities for blood sugar management and facilitate more personalized treatment strategies. For example, in December 2024, DexCom, Inc., a glucose biosensing company, introduced its proprietary Generative AI (GenAI) platform. This development made DexCom the first Continuous Glucose Monitor (CGM) manufacturer to embed GenAI into its glucose biosensing technology. The platform analyzes individual health data patterns, establishing a precise link between lifestyle choices and glucose levels, while offering actionable insights to help improve metabolic health.

A significant market driver in the diabetes management apps industry is the strategic expansion of leading medical device manufacturers, such as Abbott, Dexcom, Inc., Medtronic, and Insulet Corporation, into digital health platforms. These companies are known for their advanced glucose monitoring hardware; they increasingly integrate their devices with mobile apps and software solutions to offer a more comprehensive diabetes management ecosystem. This shift is due to patient demand for more convenient, connected care and a proactive move to capture value in the rapidly growing market.

The entry of major glucose monitoring device manufacturers into the market is owing to evolving patient needs and a strategic growth initiative. By aligning their devices with digital platforms, these companies drive market growth, improve patient outcomes, and shape the future of connected diabetes care.

Global Diabetes Management Apps Market Report Segmentation

This report forecasts revenue growth and provides a global, regional, and country levels an analysis of the latest trends in each sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global diabetes management apps market report based on type, platform, functionality, end use, subscription model, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Pre-diabetes
• Platform Outlook (Revenue, USD Million, 2018 - 2030)
• iOS
• Android
• Web-based Applications
• Integrated Digital Ecosystems
• Functionality Outlook (Revenue, USD Million, 2018 - 2030)
• Blood Glucose Monitoring Apps
• Insulin Tracking Apps
• Diet & Nutrition Planning Apps
• Physical Activity Tracking Apps
• Subscription model Outlook (Revenue, USD Million, 2018 - 2030)
• Freemium
• Subscription-Based
• One-time Purchase
• Ad-Supported
• Insurance Reimbursement-Based
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Patients
• Healthcare Providers
• Payers/Insurance Companies
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Functionality outlook
  • 2.2.3. Platform outlook
  • 2.2.4. Subscription Model outlook
  • 2.2.5. End Use outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Diabetes Management Apps Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Diabetes Management Apps: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Regulatory Landscape
• 3.5. Technology Landscape
• 3.6. Case Study Analysis
• 3.7. Healthcare Mobile App Trends in the Diabetes Management Apps Market
• 3.8. Pricing Analysis
• 3.9. Key Evaluation Metrics for Diabetes Management Apps Market
  • 3.9.1. Metrics for the key companies in the market (retention rate, churn rate, and conversion rate)
• 3.10. Consumer Behavior Analysis
  • 3.10.1. Demographic Analysis
  • 3.10.2. Consumer Trends & Preferences
• 3.11. Parameters Considered in Designing Diabetes Management Apps
• 3.12. Futuristic Trends in the Diabetes Management Apps Industry
• 3.13. Global Adoption Rates of Diabetes Management Apps

Chapter 4. Diabetes Management Apps Market Segment Analysis, By Type, 2018 - 2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Application Market Share Analysis, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Diabetes Management Apps Market, by Application, 2018 to 2030
• 4.5. Type 1 Diabetes
  • 4.5.1. Type 1 Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Type 2 Diabetes
  • 4.6.1. Type 2 Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Gestational Diabetes
  • 4.7.1. Gestational Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Pre-diabetes
  • 4.8.1. Pre-diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Diabetes Management Apps Market Segment Analysis, By Platform, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Platform Market Share Analysis, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Diabetes Management Apps Market, by Platform, 2018 to 2030
• 5.5. Android
  • 5.5.1. Android Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. iOS
  • 5.6.1. iOS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Web-based Applications
  • 5.7.1. Web-based Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Integrated Digital Ecosystems
  • 5.8.1. Integrated Digital Ecosystems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Diabetes Management Apps Market Segment Analysis, By Functionality, 2018 - 2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. Functionality Market Share Analysis, 2024 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Diabetes Management Apps Market, by Functionality, 2018 to 2030
• 6.5. Blood Glucose Monitoring Apps
  • 6.5.1. Blood Glucose Monitoring Apps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Insulin Tracking Apps
  • 6.6.1. Insulin Tracking Apps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Diet & Nutrition Planning Apps
  • 6.7.1. Diet & Nutrition Planning Apps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Physical Activity Tracking Apps
  • 6.8.1. Physical Activity Tracking Apps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Diabetes Management Apps Market Segment Analysis, By Subscription Model, 2018 - 2030 (USD Million)

• 7.1. Definition and Scope
• 7.2. Subscription Model Market Share Analysis, 2024 & 2030
• 7.3. Segment Dashboard
• 7.4. Global Diabetes Management Apps Market, by Subscription Model, 2018 to 2030
• 7.5. Freemium
  • 7.5.1. Freemium Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Subscription-Based
  • 7.6.1. Subscription-Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. One-time Purchase
  • 7.7.1. One-time Purchase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Ad-Supported
  • 7.8.1. Ad-Supported Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Insurance Reimbursement-Based
  • 7.9.1. Insurance Reimbursement-Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Diabetes Management Apps Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 8.1. Definition and Scope
• 8.2. End Use Market Share Analysis, 2024 & 2030
• 8.3. Segment Dashboard
• 8.4. Global Diabetes Management Apps Market, by End Use, 2018 to 2030
• 8.5. Healthcare Providers
  • 8.5.1. Healthcare Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Patients
  • 8.6.1. Patients Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Payers/Insurance Companies
  • 8.7.1. Payers/Insurance Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Diabetes Management Apps Market Segment Analysis, By Region, 2018- 2030 (USD Million)

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Regional Market Snapshot
• 9.4. Diabetes Management Apps Market Share by Region, 2024 & 2030:
• 9.5. North America
  • 9.5.1. North America diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.5.2. U.S.
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Regulatory Scenario
    • 9.5.2.3. Competitive Scenario
    • 9.5.2.4. U.S. diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.5.3. Canada
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Regulatory Scenario
    • 9.5.3.3. Competitive Scenario
    • 9.5.3.4. Canada diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.5.4. Mexico
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Regulatory Scenario
    • 9.5.4.3. Competitive Scenario
    • 9.5.4.4. Mexico diabetes management apps market, 2018 - 2030 (USD Million)
• 9.6. Europe
  • 9.6.1. Europe diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.6.2. UK
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Regulatory Scenario
    • 9.6.2.3. Competitive Scenario
    • 9.6.2.4. UK diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.6.3. Germany
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Regulatory Scenario
    • 9.6.3.3. Competitive Scenario
    • 9.6.3.4. Germany diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.6.4. France
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Regulatory Scenario
    • 9.6.4.3. Competitive Scenario
    • 9.6.4.4. France diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.6.5. Italy
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Regulatory Scenario
    • 9.6.5.3. Competitive Scenario
    • 9.6.5.4. Italy diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.6.6. Spain
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. Regulatory Scenario
    • 9.6.6.3. Competitive Scenario
    • 9.6.6.4. Spain diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.6.7. Norway
    • 9.6.7.1. Key Country Dynamics
    • 9.6.7.2. Regulatory Scenario
    • 9.6.7.3. Competitive Scenario
    • 9.6.7.4. Norway diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.6.8. Sweden
    • 9.6.8.1. Key Country Dynamics
    • 9.6.8.2. Regulatory Scenario
    • 9.6.8.3. Competitive Scenario
    • 9.6.8.4. Sweden diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.6.9. Denmark
    • 9.6.9.1. Key Country Dynamics
    • 9.6.9.2. Regulatory Scenario
    • 9.6.9.3. Competitive Scenario
    • 9.6.9.4. Denmark diabetes management apps market, 2018 - 2030 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Japan
    • 9.7.1.1. Key Country Dynamics
    • 9.7.1.2. Regulatory Scenario
    • 9.7.1.3. Competitive Scenario
    • 9.7.1.4. Japan diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.7.2. China
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Regulatory Scenario
    • 9.7.2.3. Competitive Scenario
    • 9.7.2.4. China diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.7.3. India
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Regulatory Scenario
    • 9.7.3.3. Competitive Scenario
    • 9.7.3.4. India diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.7.4. Australia
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Regulatory Scenario
    • 9.7.4.3. Competitive Scenario
    • 9.7.4.4. Australia diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.7.5. South Korea
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Regulatory Scenario
    • 9.7.5.3. Competitive Scenario
    • 9.7.5.4. South Korea diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.7.6. Thailand
    • 9.7.6.1. Key Country Dynamics
    • 9.7.6.2. Regulatory Scenario
    • 9.7.6.3. Competitive Scenario
    • 9.7.6.4. Thailand diabetes management apps market, 2018 - 2030 (USD Million)
• 9.8. Latin America
  • 9.8.1. Brazil
    • 9.8.1.1. Key Country Dynamics
    • 9.8.1.2. Regulatory Scenario
    • 9.8.1.3. Competitive Scenario
    • 9.8.1.4. Brazil diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.8.2. Argentina
    • 9.8.2.1. Key Country Dynamics
    • 9.8.2.2. Regulatory Scenario
    • 9.8.2.3. Competitive Scenario
    • 9.8.2.4. Argentina diabetes management apps market, 2018 - 2030 (USD Million)
• 9.9. MEA
  • 9.9.1. South Africa
    • 9.9.1.1. Key Country Dynamics
    • 9.9.1.2. Regulatory Scenario
    • 9.9.1.3. Competitive Scenario
    • 9.9.1.4. South Africa diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.9.2. Saudi Arabia
    • 9.9.2.1. Key Country Dynamics
    • 9.9.2.2. Regulatory Scenario
    • 9.9.2.3. Competitive Scenario
    • 9.9.2.4. Saudi Arabia diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.9.3. UAE
    • 9.9.3.1. Key Country Dynamics
    • 9.9.3.2. Regulatory Scenario
    • 9.9.3.3. Competitive Scenario
    • 9.9.3.4. UAE diabetes management apps market, 2018 - 2030 (USD Million)
  • 9.9.4. Kuwait
    • 9.9.4.1. Key Country Dynamics
    • 9.9.4.2. Regulatory Scenario
    • 9.9.4.3. Competitive Scenario
    • 9.9.4.4. Kuwait diabetes management apps market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Profiles
  • 10.3.1. Abbott
    • 10.3.1.1. Company overview
    • 10.3.1.2. Financial performance
    • 10.3.1.3. Platform benchmarking
    • 10.3.1.4. Strategic initiatives
  • 10.3.2. Dexcom, Inc.
    • 10.3.2.1. Company overview
    • 10.3.2.2. Financial performance
    • 10.3.2.3. Platform benchmarking
    • 10.3.2.4. Strategic initiatives
  • 10.3.3. Medtronic
    • 10.3.3.1. Company overview
    • 10.3.3.2. Financial performance
    • 10.3.3.3. Platform benchmarking
    • 10.3.3.4. Strategic initiatives
  • 10.3.4. Insulet Corporation
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Platform benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. F. Hoffmann-La Roche Ltd
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Platform benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Glooko, Inc.
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Platform benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. Diabetes: M
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Platform benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. DarioHealth Corp.
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Platform benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. LifeScan IP Holdings, LLC
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Platform benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Glucose Buddy (Azumio)
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Platform benchmarking
    • 10.3.10.4. Strategic initiatives